<DOC>
	<DOC>NCT00395343</DOC>
	<brief_summary>A clinical study to determine the safety and efficacy of sitagliptin in patients with Type 2 Diabetes Mellitus who have inadequate glycemic control on insulin or insulin/metformin combination therapy.</brief_summary>
	<brief_title>Sitagliptin Added-on to Insulin Study (0431-051)</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Patient has type 2 diabetes mellitus Patient is poorly controlled while on insulin or insulin and metformin Patient has a history of type 1 diabetes mellitus or history of ketoacidosis Patient is taking oral antidiabetic agents other than metformin during the past 3 months Patient is currently on treatment with daily use of preprandial shortacting or rapidacting insulin</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>